Modular / mobile cleanrooms

01Overview and value chain

Markers: [EC: GMP Annex 1 | OECD: Biotech & health | Regulator: FDA (USA), EMA (EU)]

Modular and mobile cleanrooms represent a paradigm shift in biomanufacturing infrastructure, replacing highly complex, multi-year “stick-built” construction projects with prefabricated, autonomous production environments. These systems range from panelized architectural enclosures assembled on-site to fully autonomous, factory-tested PODs that are dropped into existing warehouse shells. By building and qualifying the cleanrooms off-site in parallel with the host facility construction, this technology compresses project timelines by up to 50%, enabling facility commissioning in as little as 9 to 12 months. Modular cleanrooms are engineered to maintain stringent ISO 5 to ISO 8 classifications and seamlessly integrate advanced HVAC and single-use processing equipment, providing the agility required for personalized medicine and rapid vaccine scale-up.

The key directions of modular and mobile cleanrooms are:

1. Autonomous Cleanroom PODs (Prefabricated PODs): Fully self-contained units with integrated HVAC, controls, and fire suppression that can be physically relocated, repurposed, or scaled out in a “plug-and-play” fashion.
2. Panelized Modular Systems (Architectural modular): Precision-engineered wall and ceiling panel systems that form airtight, easily cleanable environments with integrated coving, assembled rapidly inside host buildings.
3. Mobile Biocontainment Labs (Mobile units): Truck-mounted or containerized high-containment laboratories (BSL-3/BSL-4) utilized for rapid deployment in outbreak zones or remote clinical trial locations.
4. Cell & Gene Therapy (CGT) Suites (Therapy workcells): Ultra-compact modular suites specifically designed to provide isolated, cross-contamination-free environments for autologous therapy manufacturing.

Sectoral value chain

[Design & HVAC Engineering] ──> [Off-site Fabrication] ──> [Factory Acceptance Testing] ──> [Logistics & Site Delivery]
                                  │
                          (Host Facility Prep)
                                  │
                                  ▼
[Biopharma Manufacturing] <─── [Site Assembly & Qualification] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• Integrated HEPA/ULPA filtration: Advanced air-handling units built directly into the ceiling plenums of the modules to maintain unidirectional airflow and ISO-compliant particle counts.
• VHP-resistant materials: Wall panels constructed from uPVC or specialized epoxy-coated steel designed to withstand thousands of vaporized hydrogen peroxide (VHP) decontamination cycles without degrading.
• Smart facility controls: Centralized building management systems (BMS) that actively monitor and adjust pressure differentials, temperature, and humidity across interconnected PODs.

02US

The United States dominates the development and deployment of fully autonomous cleanroom PODs, largely driven by the explosive growth of the domestic cell and gene therapy (CGT) sector.

POD manufacturing, CGT scale-out, rapid deployment

• Autonomous POD pioneers: Texas-based G-CON Manufacturing has established the global gold standard for autonomous cleanroom PODs, enabling biopharma to scale out capacity predictably.
• Mobile biocontainment: Companies like Germfree specialize in deploying fully mobile, high-containment laboratories for government biodefense initiatives and remote clinical manufacturing.
• Flexible CDMO infrastructure: US-based contract manufacturers heavily favor modular infrastructure to rapidly reconfigure their floor plans between disparate client campaigns, maximizing facility utilization.

03CN

China relies heavily on panelized modular cleanroom systems to rapidly construct the immense biomanufacturing capacities required for domestic biologics production.

Panelized systems, massive scale, cost efficiency

• Enclosure system dominance: Mega-manufacturers like Wiskind Cleanroom provide vast quantities of precision-engineered cleanroom wall and ceiling panels, driving down the capital expenditure for new facilities.
• Speed to market: Driven by aggressive national health mandates, Chinese biopharma leverages modular construction to build multi-million-liter bioreactor facilities in a fraction of Western timelines.
• Domestic integration: China is actively integrating localized HVAC and BMS technologies into their modular offerings to eliminate reliance on imported European cleanroom technology.

04EU

The European Union combines legacy architectural engineering expertise with rigorous regulatory compliance to deliver sophisticated, highly customized modular facilities.

Turnkey facilities, architectural precision, Annex 1 compliance

• Turnkey facility engineering: Industry giants like Exyte leverage modular frameworks (e.g., ExyCell) to deliver complete, turnkey biomanufacturing facilities globally.
• Italian precision: Manufacturers like Nicomac dominate the high-end market for architectural modular cleanrooms, specializing in flawless glass integration and flush-mounted utility panels.
• Regulatory rigor: European modular systems are explicitly engineered to ensure seamless compliance with the updated EU GMP Annex 1 guidelines, particularly regarding absolute contamination control strategies.

05Leading companies and research institutes

06Tech stack and innovations

Modular cleanrooms utilize advanced materials science and fluid dynamics to create strictly controlled micro-environments within varied macro-environments.

1. Autonomous Air Handling:
   • Dedicated HVAC systems mounted directly onto the POD roof or integrated into the mechanical space.
   • Provides completely independent temperature, humidity, and particle control, preventing cross-contamination via shared facility ductwork.
2. Cold-Welded uPVC Finishes:
   • Wall and floor joints are chemically or thermally welded to create a single, continuous, non-porous surface.
   • Eliminates micro-crevices where bacteria or mold could evade rigorous chemical decontamination.
3. Active Pressure Cascading:
   • Intelligent damper systems automatically adjust air supply and exhaust to maintain positive pressure gradients (e.g., +15 Pa) from the most critical processing area out to the gowning rooms.

07Value chains and production pipelines

Industrial pipeline of Modular Facility Commissioning (ISO 14644)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. 3D facility modeling   │ ───> │ 2. Factory fabrication    │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Site transport & rigging│ <─── │ 3. Factory Acceptance (FAT)│
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Physical integration   │ ───> │ 6. IQ/OQ/PQ Validation    │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: 3D facility modeling

Engineers utilize advanced Building Information Modeling (BIM) software to design the modular cleanrooms, routing process gases, electrical conduits, and HVAC ducting with millimeter precision to avoid physical clashes.

Stage 2: Factory fabrication

In a controlled manufacturing environment, the modular skeletons are welded, insulated wall panels are installed, and dedicated air handling units (AHUs) are integrated onto the module’s roof structure.

Stage 3: Factory Acceptance (FAT)

The fully assembled module is temporarily powered on the factory floor. Engineers rigorously test airflow velocities, HEPA filter integrity, and pressure cascades to ensure the room meets strict ISO specifications before it ever ships.

Stage 4: Site transport & rigging

The modules are shrink-wrapped and loaded onto specialized wide-load trailers. Upon arriving at the host facility site, large gantry cranes or air-bearings are used to slide the multi-ton PODs into their final position.

Stage 5: Physical integration

Technicians physically dock the modules together, sealing the seams with pharmaceutical-grade caulk, and connect the unit’s single-point-of-connection (SPOC) umbilical to the host facility’s chilled water and power grids.

Stage 6: IQ/OQ/PQ Validation

Third-party validation teams execute the Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). They conduct extensive smoke studies and particle counts, culminating in a GMP-ready manufacturing suite.